Sterol regulatory element binding protein 1 promotes proliferation and invision of prostate cancer cells

doi:10.16352/j.issn.1001-6325.2025.02.0189

Abstract

Abstract: Objective Exploring the expression of sterol regulatory element-binding protein 1 (SREBP1) and acetyl-CoA carboxylase alpha(ACCα) in prostate cancer tissues and their impact on proliferation, migration and invasion of prostate cancer cells DU145. Methods The expression levels of SREBP1 and ACCα in prostate cancer tissue were analyzed using online databases including TIMER, UALCAN, GEPIA, and THE HUMAN PROTEIN ATLAS. Paraffin-embedded specimens from 58 cases of prostate cancer (PCa) and 58 cases of benign prostatic hyper- plasia(BPH) diagnosed at the Fifth Affiliated Hospital of Zunyi Medical University from January 2016 to December 2018 were collected. Immunohistochemistry was used to detect the expression of SREBP1 and ACCα in these tissues. Following the knockdown of SREBP1 in DU145 cells using shRNA, the changes in ACCα expression were assessed by qRT-PCR. The CCK-8 assay was employed to evaluate cell proliferation, while flow cytometry was used to analyze cell cycle distribution. Western blot was performed to measure the expression of SREBP1 and ACCα. Transwell assays were conducted to assess changes in migration and invasion capabilities after silencing SREBP1 in DU145 cells. Scratch assays were used to examine the impact of SREBP1 knockdown on the healing capability of DU145 cells. EdU assays were performed to detect changes in cell proliferation following the silencing of SREBP1. Oil Red O staining was utilized to observe changes in lipid content within prostate cancer cells after interference with SREBP1 expression. Results Analysis using online databases such as TIMER and UALCAN revealed that ACCα expression was significantly elevated in prostate cancer tissues compared to normal prostate tissues (P＜0.001). After silencing SREBP1, the proliferation, migration and invasion capability of DU145 cells were significantly reduced compared to the control group (P＜0.01), and flow cytometric analysis showed G1 phase arrested in DU145 cells (P＜0.01). Knockdown of SREBP1 resulted in a significant decrease in lipid content in prostate cancer cells (P＜0.01). Conclusions SREBP1 may promote the proliferation, migration and invasion of prostate cancer cells through regulating the expression of ACCα.

Key words: prostate cancer, acetyl-CoA carboxylase alpha, sterol regulatory element-binding protein 1(SREBP1), Warburg effect, lipid metabolism

CLC Number:

R737.25

JIANG Hua, ZHANG He, JIANG Songsong. Sterol regulatory element binding protein 1 promotes proliferation and invision of prostate cancer cells[J]. Basic & Clinical Medicine, 2025, 45(2): 189-196.

References 15

[1]	Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134:783-791.
[2]	Pollack A, Pra AD. Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management[J]. Lancet, 2024, 403:2353-2355.
[3]	Kocianova E, Piatrikova V, Golias T. Revisiting the Warburg effect with focus on lactate[J]. Cancers (Basel), 2022,14:6028.doi: 10.3390/cancers14246028.
[4]	Wang Y, Patti GJ. The Warburg effect: a signature of mitochondrial overload[J]. Trends Cell Biol, 2023, 33:1014-1020.
[5]	Barba I, Carrillo-Bosch L, Seoane J. Targeting the warburg effect in cancer: where do we stand?[J]. Int J Mol Sci, 2024; 25:3142.doi: 10.3390/ijms25063142.
[6]	Lebelo MT, Joubert AM, Visagie MH. Warburg effect and its role in tumourigenesis[J]. Arch Pharm Res, 2019, 42:833-847.
[7]	Gonthier K, Weidmann C, Berthiaume L, et al. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer[J]. Mol Oncol, 2023, 17:2109-2125.
[8]	Zhang H, Liu S, Cai Z, et al. Down-regulation of ACACA suppresses the malignant progression of prostate cancer through inhibiting mitochondrial potential.[J] J Cancer, 2021, 12:232-243.
[9]	Park IJ, Kim MJ, Park OJ, et al. Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation[J]. Cancer Lett, 2010, 298:88-98.
[10]	Geng F, Guo D. SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth[J]. Autophagy, 2024, 20:1183-1185.
[11]	Li X, Chen YT, Josson S, et al. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells[J]. PLoS One, 2013, 8:e70987.doi: 10.3390/ijms25063142.
[12]	Fukuda M, Ogasawara Y, Hayashi H, et al. Resvera-trol inhibits proliferation and induces autophagy by blocking SREBP1 expression in oral cancer cells[J]. Molecules, 2022,27:8250. doi: 10.3390/molecules27238250.
[13]	He Y, Qi S, Chen L, et al. The roles and mechanisms of SREBP1 in cancer development and drug response[J]. Genes Dis, 2024, 11:100987.doi: 10.1016/j.gendis.2023.04.022.
[14]	Fhu CW, Ali A. Fatty acid synthase: an emerging target in cancer[J]. Molecules, 2020, 25:3935. doi: 10.3390/molecules25173935.
[15]	Zhang Y, Chen XN, Zhang H, et al. CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA[J]. Cell Death Differ, 2023, 30:2462-2476.